Haisco Pharmaceutical Group Co., Ltd. at its 2nd Extraordinary General Meeting of 2023 on 25 August 2023, during which the following proposal(s) was/were approved: Election and nomination of non-independent directors, cumulative voting system applicable: Wang Junmin, Fan Xiulian, Zheng Wei, Yan Pangke. Election and nomination of independent directors, cumulative voting system applicable: Yue Lin and Cao Chuande. Election of shareholder supervisors, cumulative voting system applicable: Liang Yuan and Sun Tao.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.21 CNY | +0.03% | -1.37% | +30.50% |
Apr. 19 | Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 18 | Haisco Pharmaceutical Gets Nod to Trial HSK16149 Capsules | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.50% | 4.61B | |
+30.73% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+14.72% | 239B | |
+9.86% | 210B | |
-7.40% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- 002653 Stock
- News Haisco Pharmaceutical Group Co., Ltd.
- Haisco Pharmaceutical Group Co., Ltd. Announces Management Changes